In vitro and in vivo experiments using pancreatic cancer cell lines have demonstrated that CDH-17-targeted NIR-PIT could induce specific cytotoxicity against CDH-17-expressing cells and inhibit tumor progression in a xenograft model of pancreatic cancer [154]. The gene discussed is CDH17; the disease is pancreatic neoplasm.